Therapeutic persistence with infliximab was associated with signifi cantly fewer ulcerative colitis patients requiring hospitalization; once hospitalized, patients with therapeutic persistence had significantly decreased inpatient costs.
Paula Smith, MS
Advertisement
Articles by Paula Smith, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
2
Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment
3
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
4
CKD Stage, Proteinuria Tied to Higher HCRU in IgAN
5